Arizona Athletics

NCAA suspends Trier again for failed drug test

Arizona and Allonzo Trier have been hit with another major setback. The NCAA has declared Allonzo Trier ineligible. It is not clear how long the ineligibity will take.

Arizona officials sent out the news about 4:10 p.m. on Thursday, three hours before UA was to face Oregon State in Corvallis, Ore.

Photo courtesy Stan Liu, Arizona Athletics

“Earlier today, the University of Arizona was notified that the NCAA has declared Allonzo Trier ineligible,” Arizona said in the one-paragraph statement. “In late January 2018, Allonzo participated in an NCAA student-athlete drug screening. The results of that test, confirmed today, revealed the reappearance of a trace amount of a banned substance. The amount detected was miniscule by scientific standards and appears to be a remnant of a substance, which the NCAA agreed, Allonzo had unknowingly ingested in 2016. The University is appealing the decision and is hopeful that Allonzo will regain his eligibility soon.”

This will make the third consecutive season Trier has had to deal with something that has halted his playing career for that specific season. Two years ago, he suffered a broken wrist and last year was declared inelible because of a banned substance was found in his system.

Trier, a junior, is going through his best season of his career, averaging 19.6 points per game, 3.2 assists and 3.2 rebounds a game.

What Trier’s suspension does is continue Arizona’s season-long misfortune as it pertains to players and/or coaches. UA is currently under FBI investigation for recruiting irregularities. It resulted in the firing of former UA assistant coach Book Richardson. Additionally, sophomore Rawle was out the early part of the season after he suffered a foot injury in September. He was experiencing soreness as recently as late last month.

No. 14 Arizona (21-6) has struggled to reach its expectations all season and is now projected to be a No. 4 seed in next month’s NCAA Tournament.

print
Print Friendly, PDF & Email
Comments
To Top